U.S. Markets open in 56 hrs, 52 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 5.68 11:45 AM EDT | |
|---|---|---|
| Day High | 6.00 09:30 AM EDT |
|
| Range | 0.32 |
| Volume | 711,689 | |
|---|---|---|
| 30-Day Avg Vol | 1.65 M |
|
| Difference | -57.05% |
| Market Cap | 445.86 M | |
|---|---|---|
| Mkt Cap Chg | -23.22 M |
| Shares Out | 77.40 M | |
|---|---|---|
| % Shrs Traded | 0.92% | |
| 1yr EPS Est | 0.596 |
| 52-Wk Low | 3.79 3/3/09 | |
|---|---|---|
| 52-Wk High | 15.16 9/3/08 |
|
| Range | 11.37 |
| Prev Close | 6.06 7/1/09 | |
|---|---|---|
| Today's Open | 6.00 | |
| Change | -0.99% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.17 M |
| Revenue (LFY) | 232.30 M | |
|---|---|---|
| Earnings (LFY) | 67.62 M | |
| Earnings (MRQ) | -59.22 M | |
| Next Earn Est | 0.182 | |
| Next Earnings | 07/27/2009 |
|
| EPS (TTM) | -0.15 | |
| 1yr EPS Growth | 497.33% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 9.60 | |
| PEG Ratio | 0.62 | |
| Return on Equity | 9.61 | |
| Beta | 2.03 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
ViroPharma didn't want to wait until its drugs were approved to start making money, so it bought one that was already approved. The development-stage firm discovers drugs to combat RNA viruses, a category ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.182 7/27/09 | — — |
—
—
|
| Last Quarter | 0.159 3/31/09 | -0.77 3/31/09 |
-0.929
Missed
|
| 2 Quarters Ago | 0.153 12/31/08 | -0.01 12/31/08 |
-0.163
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 60.19 M | 232.31 M |
| Gross Profit | 49.00 M | 212.62 M |
| Operating Income | 4.94 M | 80.92 M |
| Net Income | -59.22 M | 67.62 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts